Elevance Health Now Expects 2024 Benefit Expense Ratio To Be Approximately 88.5% And Operating Cash Flow To Be $4.5B, Principally Due To Headwinds In Medicaid Business
Portfolio Pulse from Benzinga Newsdesk
Elevance Health has adjusted its expectations for 2024, projecting a benefit expense ratio of approximately 88.5% and operating cash flow of $4.5 billion, primarily due to challenges in its Medicaid business.
October 17, 2024 | 11:27 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Elevance Health has revised its 2024 financial expectations, citing headwinds in its Medicaid business. The company now anticipates a benefit expense ratio of 88.5% and operating cash flow of $4.5 billion.
The revision in financial expectations, particularly due to Medicaid business challenges, suggests potential financial strain, which could negatively impact investor sentiment and short-term stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100